vimarsana.com
Home
Live Updates
Praxis Precision Stock Jumps 26% On Positive Results For Phase 2 Study Of Epilepsy Treatment : comparemela.com
Praxis Precision Stock Jumps 26% On Positive Results For Phase 2 Study Of Epilepsy Treatment
Shares of Praxis Precision Medicines, Inc. (PRAX) jumped over 26% on Tuesday morning after the company reported positive results from a phase 2 study of epilepsy treatment.
Related Keywords
Marcio Souza ,
Praxis Precision Medicines Inc ,
Nasdaq ,
Praxis Precision Medicines ,
Precision Medicines ,
Photo Paroxysmal Response ,
Praxis Precision ,
comparemela.com © 2020. All Rights Reserved.